open access, immunology
Antiviral Immunotherapy Comes of Age
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 
Immune System Targets Diverse Viruses Using the Same Small Peptide
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
A Growing Open Access Toolbox
A Growing Open Access Toolbox
Diana Kwon | Nov 28, 2017
Legal methods to retrieve paywalled articles for free are on the rise, but better self-archiving practices could help improve accessibility. 
European Research Council Founder, Molecular Biologist Dies
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
ResearchGate Restricts Access to Nearly 2 Million Articles
ResearchGate Restricts Access to Nearly 2 Million Articles
Catherine Offord | Nov 9, 2017
The academic social network is bending to pressure from publishing giants that demand it removes copyrighted material from its site.
American Chemical Society Wins Lawsuit Against Sci-Hub
American Chemical Society Wins Lawsuit Against Sci-Hub
Diana Kwon | Nov 7, 2017
A US judge issues a broad injunction that allows the society to demand that technology companies actively associated with the site block access to it.
Opinion: Share Your Data
Opinion: Share Your Data
Cameron Craddock, Arno Klein, Michael P. Milham | Oct 24, 2017
Our analysis of a collection of open-access datasets quantifies their benefit to the scientific community.
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Compound Found in Red Wine Boosts Immune Cell Function
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling.